{"id":"https://openalex.org/W1788528477","doi":null,"title":"Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients.","display_name":"Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients.","publication_year":2011,"publication_date":"2011-02-01","ids":{"openalex":"https://openalex.org/W1788528477","mag":"1788528477","pmid":"https://pubmed.ncbi.nlm.nih.gov/21389294"},"language":"en","primary_location":{"id":"pmid:21389294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21389294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the American Osteopathic Association","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031874101","display_name":"Craig Spellman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12315562","display_name":"Texas Tech University","ror":"https://ror.org/0405mnx93","country_code":"US","type":"education","lineage":["https://openalex.org/I12315562"]},{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Craig W Spellman","raw_affiliation_strings":["Center for Diabetes and Metabolic Disorders, Texas Tech University Health Science Center, Midland-Odessa, TX 79763-4206, USA. craig.spellman@ttuhsc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Diabetes and Metabolic Disorders, Texas Tech University Health Science Center, Midland-Odessa, TX 79763-4206, USA. craig.spellman@ttuhsc.edu","institution_ids":["https://openalex.org/I12315562","https://openalex.org/I926076166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031874101"],"corresponding_institution_ids":["https://openalex.org/I12315562","https://openalex.org/I926076166"],"apc_list":null,"apc_paid":null,"fwci":0.4108,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.65245493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"111","issue":"2 Suppl 1","first_page":"eS10","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8939999938011169},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9269999861717224},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.8270000219345093},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.8500000238418579},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.9629999995231628},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hypoglycemia-risk","display_name":"hypoglycemia risk","score":0.8389999866485596},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metformin-intolerance","display_name":"metformin intolerance","score":0.925000011920929},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8610000014305115},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9307335615158081},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.817078709602356},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6010816693305969},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5751150250434875},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5659686326980591},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5430736541748047},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5330022573471069},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49698713421821594},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48382702469825745},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.47599589824676514},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47011080384254456},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4208196997642517},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.42055171728134155},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.4131700396537781},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.412274569272995}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:21389294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21389294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the American Osteopathic Association","raw_type":"Case Reports"},{"id":"mag:1788528477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21389294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1491092293","https://openalex.org/W1905803407","https://openalex.org/W2000976083","https://openalex.org/W2005230361","https://openalex.org/W2027686692","https://openalex.org/W2038234704","https://openalex.org/W2042845313","https://openalex.org/W2054564814","https://openalex.org/W2069417225","https://openalex.org/W2070271057","https://openalex.org/W2070710390","https://openalex.org/W2081276121","https://openalex.org/W2093545531","https://openalex.org/W2098289172","https://openalex.org/W2103525547","https://openalex.org/W2108771199","https://openalex.org/W2109728760","https://openalex.org/W2129811887","https://openalex.org/W2146901298","https://openalex.org/W2159205789","https://openalex.org/W2162708888","https://openalex.org/W2169558934","https://openalex.org/W2170606300","https://openalex.org/W2207468142","https://openalex.org/W2337454357"],"related_works":["https://openalex.org/W2119355349","https://openalex.org/W2095287352","https://openalex.org/W2731445304","https://openalex.org/W2887036440","https://openalex.org/W2652429844","https://openalex.org/W2428088692","https://openalex.org/W952614140","https://openalex.org/W2093127997","https://openalex.org/W4395478403","https://openalex.org/W7163125755"],"abstract_inverted_index":{"The":[0],"pathophysiology":[1],"of":[2,10,24,113,130,142,157],"type":[3],"2":[4],"diabetes":[5],"mellitus":[6],"is":[7,133],"complex,":[8],"consisting":[9],"far":[11],"more":[12],"physiologic":[13],"defects":[14],"than":[15],"simple":[16],"insulin":[17,61],"resistance":[18],"and":[19,48,73,96,121,147],"\u03b2-cell":[20,79],"dysfunction.":[21],"Our":[22],"understanding":[23],"this":[25],"progressive":[26],"disease":[27],"has":[28],"moved":[29],"from":[30],"a":[31,139],"\"dual":[32],"defect\"":[33],"to":[34,85],"an":[35,82],"\"ominous":[36],"octet\"":[37],"description.":[38],"This":[39],"multifactoral":[40],"concept":[41],"may":[42,74,106],"explain":[43],"the":[44,92,154],"difficulty":[45],"in":[46,110,116,124],"achieving":[47],"maintaining":[49],"glycemic":[50],"goals":[51],"with":[52,100,118,160],"traditional":[53],"therapies.":[54],"Glucagon-like":[55,103],"peptide-1":[56,104],"(GLP-1)":[57],"agonists,":[58],"which":[59],"improve":[60],"secretion,":[62,65],"decrease":[63,70],"glucagon":[64],"increase":[66],"satiety":[67],"(and":[68],"therefore":[69],"food":[71],"intake),":[72],"have":[75,138],"beneficial":[76],"effects":[77],"on":[78],"function,":[80],"represent":[81],"important":[83],"addition":[84],"treatment":[86],"options.":[87],"Their":[88],"glucose-dependent":[89],"mechanism":[90],"limits":[91],"risk":[93],"for":[94],"hypoglycemia,":[95],"they":[97,137],"are":[98],"associated":[99],"weight":[101],"loss.":[102],"agonists":[105,159],"be":[107],"used":[108],"alone":[109],"patients":[111],"intolerant":[112],"metformin":[114],"or":[115],"combination":[117,126],"metformin,":[119],"thiazolidinediones,":[120],"sulfonylureas":[122],"(or":[123],"any":[125],"therereof).":[127],"Concomitant":[128],"use":[129,156],"dipeptidyl-peptidase-4":[131],"inhibitors":[132],"not":[134,152],"recommended":[135],"because":[136],"similar":[140],"basis":[141],"action.":[143],"Current":[144],"US":[145],"Food":[146],"Drug":[148],"Administration":[149],"indications":[150],"do":[151],"include":[153],"concomitant":[155],"GLP-1":[158],"insulin.":[161]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}